Ipratropium recalls

The FDA has published 6 recalls involving Ipratropium since 2015. The latest was reported on 1 May 2024. Most were for manufacturing (cgmp) deviations. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls6since 2015

Last 12 months0reported

Class I00% of total

Ongoing0latest 1 May 2024

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 5 83%Class III 1 17%

Why ipratropium is recalled

Companies

Mckesson Medical-Surgical Inc. Corporate Office233%
Nephron Pharmaceuticals117%
Boehringer Ingelheim Roxane117%
Cipla USA117%
Cardinal Healthcare117%

Brands

Ipratropium Bromide And Albuterol Sulfate467%
Ipratropium Bromide117%
Combivent Respimat117%

By year

2024233%
2022233%
2015233%

All ipratropium recalls, newest first

6 total

Reported	Class	Recall	Company	Reason	Where
1 May 2024Drug	CLASS II	Ipratropium Bromide and Albuterol Sulfate Inhalation recalledIpratropium Bromide And Albuterol Sulfate	Cipla USA	Packaging Defects	Nationwide
3 Jan 2024Drug	CLASS II	Ipratropium Bromide and Albuterol Sulfate Inhalation recalledIpratropium Bromide And Albuterol Sulfate	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide
15 Jun 2022Drug	CLASS III	Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg recalledIpratropium Bromide And Albuterol Sulfate	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
15 Jun 2022Drug	CLASS II	Ipratropium Bromide Inhalation Solution, 0.02%, 0.5 mg recalledIpratropium Bromide	Mckesson Medical-Surgical Inc. Corporate Office	Manufacturing (CGMP) Deviations	Nationwide
21 Oct 2015Drug	CLASS II	Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg recalledIpratropium Bromide And Albuterol Sulfate	Nephron Pharmaceuticals	Sterility	Nationwide
5 Aug 2015Drug	CLASS II	Combivent Respimat (ipratropium bromide recalledCombivent Respimat	Boehringer Ingelheim Roxane	Other	Nationwide

Should you stop taking Ipratropium?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.